The effects of local progesterone on stilbestrol-associated vaginal adenosis.
D000022:Abortion, Spontaneous / Q000517:prevention & control; D000293:Adolescent; D000328:Adult; D003593:Cytoplasm; D004054:Diethylstilbestrol / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004847:Epithelial Cells; D004848:Epithelium / Q000473:pathology; D005260:Female; D006003:Glycogen; D006801:Humans; D008598:Menstruation; D008679:Metaplasia / Q000473:pathology; D011230:Precancerous Conditions / Q000473:pathology; D011247:Pregnancy; D011374:Progesterone / Q000008:administration & dosage / Q000097:blood / Q000627:therapeutic use*; D013194:Staining and Labeling; D013488:Suppositories; D014621:Vagina / Q000166:cytology; D014623:Vaginal Diseases / Q000139:chemically induced / Q000188:drug therapy* / Q000473:pathology; D014625:Vaginal Neoplasms / Q000473:pathology
D013488:Suppositories; D011374:Progesterone; D004054:Diethylstilbestrol; D006003:Glycogen